Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman’s breast density and individual risk factors.
More...